These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1163 related articles for article (PubMed ID: 10516703)

  • 1. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study.
    Meyers B; Borrego F; Papanicolaou G
    Liver Transpl; 2001 Aug; 7(8):750-1. PubMed ID: 11510024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A38-49. PubMed ID: 11577363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
    Saito T; Seo S; Kanda Y; Shoji N; Ogasawara T; Murakami J; Tanosaki R; Tobinai K; Takaue Y; Mineishi S
    Am J Hematol; 2001 Jul; 67(3):206-9. PubMed ID: 11391721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
    Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
    N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
    Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infection prophylaxis in patients with hematological malignancies (I)--Successful prophylaxis of Pneumocystis carinii pneumonitis with sulfamethoxazole-trimethoprim].
    Moriuchi Y; Kamihira S; Satoh T; Yanagisako T; Miyazaki Y; Nagai K; Murata K; Tokunaga S; Maeda T; Atogami S
    Rinsho Ketsueki; 1990 Nov; 31(11):1818-22. PubMed ID: 2287067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation.
    Maltezou HC; Petropoulos D; Choroszy M; Gardner M; Mantzouranis EC; Rolston KV; Chan KW
    Bone Marrow Transplant; 1997 Nov; 20(10):879-81. PubMed ID: 9404930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing PCP therapy.
    Torres G; Cadman J
    GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful prevention of Pneumocystis carinii infection with 1,920 mg of trimethoprim-sulfamethoxazole daily in patients with malignant hematopoietic diseases].
    Lemez P; Rysková P; Votava V; Suchmová M; Jirásek A; Rubík I
    Vnitr Lek; 1995 Oct; 41(10):688-91. PubMed ID: 8578700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy.
    Chung JB; Armstrong K; Schwartz JS; Albert D
    Arthritis Rheum; 2000 Aug; 43(8):1841-8. PubMed ID: 10943875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
    AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
    Chan C; Montaner J; Lefebvre EA; Morey G; Dohn M; McIvor RA; Scott J; Marina R; Caldwell P
    J Infect Dis; 1999 Aug; 180(2):369-76. PubMed ID: 10395851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
    Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
    Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.